Close Menu

NEW YORK (GenomeWeb) – Guardant Health and Flatiron Health have announced a collaboration to integrate Guardant Health's liquid biopsy genomic testing results with clinical treatment and outcomes data using Flatiron's cloud-based information platform. 

The partners said this new ability to link patients' genomic data with their clinical records will hopefully support the accelerated development of targeted therapies for cancer by enabling life science companies to more quickly recruit and select patients for trials and to more easily follow subjects and their progress over time.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.